pmid,title,journal,year,drug,disease
40736492,Top 20 Research Studies of 2024 for Primary Care Physicians.,American family physician,2025,Molnupiravir,Heart Failure
40204015,Safety and Effectiveness of Nirmatrelvir-Ritonavir in Patients With Advanced Kidney Dysfunction and COVID-19.,American journal of kidney diseases : the official journal of the National Kidney Foundation,2025,Molnupiravir,Heart Failure
40010631,Risk of postacute sequelae of COVID-19 and oral antivirals in adults aged over 60 years: A nationwide retrospective cohort study.,International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases,2025,Molnupiravir,Heart Failure
38710190,Association of nirmatrelvir-ritonavir with post-acute sequelae and mortality in patients admitted to hospital with COVID-19: a retrospective cohort study.,The Lancet. Infectious diseases,2024,Molnupiravir,Heart Failure
37522355,Effectiveness of oral antiviral agents on long-term cardiovascular risk in nonhospitalized patients with COVID-19: A multicenter matched cohort study.,Journal of medical virology,2023,Molnupiravir,Heart Failure
37016985,Erythema multiforme major associated with molnupiravir treatment for SARS-CoV-2 infection: First report.,Journal of the European Academy of Dermatology and Venereology : JEADV,2023,Molnupiravir,Heart Failure
36680111,Impact of Early SARS-CoV-2 Antiviral Therapy on Disease Progression.,Viruses,2022,Molnupiravir,Heart Failure
36362691,Molnupiravir Outpatient Treatment for Adults with COVID-19 in a Real-World Setting-A Single Center Experience.,Journal of clinical medicine,2022,Molnupiravir,Heart Failure
36358196,Real-Life Experience of Molnupiravir in Hospitalized Patients Who Developed SARS-CoV2-Infection: Preliminary Results from CORACLE Registry.,"Antibiotics (Basel, Switzerland)",2022,Molnupiravir,Heart Failure
